These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19556916)

  • 21. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.
    Mehta P; Antao V; Kaye W; Sanchez M; Williamson D; Bryan L; Muravov O; Horton K; ;
    MMWR Suppl; 2014 Jul; 63(7):1-14. PubMed ID: 25054277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic Review of Therapeutic Physical Exercise in Patients with Amyotrophic Lateral Sclerosis over Time.
    Ortega-Hombrados L; Molina-Torres G; Galán-Mercant A; Sánchez-Guerrero E; González-Sánchez M; Ruiz-Muñoz M
    Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33530383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strictly monitored exercise programs reduce motor deterioration in ALS: preliminary results of a randomized controlled trial.
    Lunetta C; Lizio A; Sansone VA; Cellotto NM; Maestri E; Bettinelli M; Gatti V; Melazzini MG; Meola G; Corbo M
    J Neurol; 2016 Jan; 263(1):52-60. PubMed ID: 26477027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.
    Mehta P; Kaye W; Bryan L; Larson T; Copeland T; Wu J; Muravov O; Horton K
    MMWR Surveill Summ; 2016 Aug; 65(8):1-12. PubMed ID: 27490513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Exercise in Patients With Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
    Meng L; Li X; Li C; Tsang RCC; Chen Y; Ge Y; Gao Q
    Am J Phys Med Rehabil; 2020 Sep; 99(9):801-810. PubMed ID: 32452880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mixed Comparison of Different Exercise Interventions for Function, Respiratory, Fatigue, and Quality of Life in Adults With Amyotrophic Lateral Sclerosis: Systematic Review and Network Meta-Analysis.
    Zhu Y; Xu Y; Xuan R; Huang J; István B; Fekete G; Gu Y
    Front Aging Neurosci; 2022; 14():919059. PubMed ID: 35898325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical recognition and management of amyotrophic lateral sclerosis: the nurse's role.
    Clarke K; Levine T
    J Neurosci Nurs; 2011 Aug; 43(4):205-14. PubMed ID: 21796043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyotrophic lateral sclerosis: Lou Gehrig's disease.
    Walling AD
    Am Fam Physician; 1999 Mar; 59(6):1489-96. PubMed ID: 10193591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-frequency motor rehabilitation in amyotrophic lateral sclerosis: a randomized clinical trial.
    Zucchi E; Vinceti M; Malagoli C; Fini N; Gessani A; Fasano A; Rizzi R; Sette E; Cavazza S; Fiocchi A; Buja S; Faccioli T; Storani S; Mandrioli J
    Ann Clin Transl Neurol; 2019 May; 6(5):893-901. PubMed ID: 31139687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nutrition management methods effective in increasing weight, survival time and functional status in ALS patients: a systematic review.
    Kellogg J; Bottman L; Arra EJ; Selkirk SM; Kozlowski F
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):7-11. PubMed ID: 28799809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current perspectives on neuromodulation in ALS patients: A systematic review and meta-analysis.
    Jiménez-García AM; Bonnel G; Álvarez-Mota A; Arias N
    PLoS One; 2024; 19(3):e0300671. PubMed ID: 38551974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyotrophic lateral sclerosis: update for family physicians.
    Shoesmith CL; Strong MJ
    Can Fam Physician; 2006 Dec; 52(12):1563-9. PubMed ID: 17279237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An assessment of treatment guidelines, clinical practices, demographics, and progression of disease among patients with amyotrophic lateral sclerosis in Japan, the United States, and Europe.
    Takei K; Tsuda K; Takahashi F; Hirai M; Palumbo J
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Oct; 18(sup1):88-97. PubMed ID: 28872912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscle-Bone Crosstalk in Amyotrophic Lateral Sclerosis.
    Zhou J; Yi J; Bonewald L
    Curr Osteoporos Rep; 2015 Oct; 13(5):274-9. PubMed ID: 26223903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of muscle exercise in patients with amyotrophic lateral sclerosis.
    Drory VE; Goltsman E; Reznik JG; Mosek A; Korczyn AD
    J Neurol Sci; 2001 Oct; 191(1-2):133-7. PubMed ID: 11677004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.
    Bruneteau G; Simonet T; Bauché S; Mandjee N; Malfatti E; Girard E; Tanguy ML; Behin A; Khiami F; Sariali E; Hell-Remy C; Salachas F; Pradat PF; Fournier E; Lacomblez L; Koenig J; Romero NB; Fontaine B; Meininger V; Schaeffer L; Hantaï D
    Brain; 2013 Aug; 136(Pt 8):2359-68. PubMed ID: 23824486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Edaravone: a new hope for deadly amyotrophic lateral sclerosis.
    Bhandari R; Kuhad A; Kuhad A
    Drugs Today (Barc); 2018 Jun; 54(6):349-360. PubMed ID: 29998226
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.